Skip to main content
. 2015 Oct 12;47(6):2082–2090. doi: 10.3892/ijo.2015.3196

Table I.

The baseline demographics of the patients.

Characteristics N=64 (%)
Age (years)
Mean ± SD 67±8
Gender
 Female 27 (42)
 Male 37 (58)
Pathological stage
 IA 22 (34)
 IB 16 (25)
 IIA 4 (6)
 IIB 3 (5)
 III 0 (0)
 IV (recurrence included)
Chemotherapy
 1st line 6 (9)
 2nd line 6 (9)
 3rd or later line 7 (11)
Pathological classification
 Adenocarcinoma 51 (80)
 Squamous cell carcinoma 10 (16)
 Others 3 (5)
EGFR mutation
 Positive 22 (34)
 Negative 31 (48)
 Unknown 11 (17)

EGFR, epidermal growth factor receptor.